ASH Annual Meeting & Exposition: Street Team | Conference

Jeffrey Wolf, MD, on Implications of Findings from Multiple Myeloma Study Presented at ASH
December 27, 2020

Wolf touched on the implications of results from a study investigating outcomes when making clinical decisions based on the MRD status of patients with multiple myeloma.

Guido Lancman, MD, on the Study Design of IVIG in Patients with Multiple Myeloma Receiving Daratumumab
December 26, 2020

A study of the effect of intravenous immunoglobulin (IVIG) on infections in patients with multiple myeloma receiving daratumumab indicated that hypogammaglobulinemia was nearly universal during treatment, suggesting a role for IVIG.

Lisa La on the Design of a Study Evaluating Diabetes in Patients with Multiple Myeloma
December 23, 2020

The director of clinical research in the Center for Cancer Care at White Plains Hospital explained the design of the study which evaluated diabetic versus nondiabetic patients enrolled in the CONNECT Multiple Myeloma Registry.